Suppr超能文献

肾细胞癌微血管密度的新定义:血管生成加血管生成拟态。

A novel definition of microvessel density in renal cell carcinoma: Angiogenesis plus vasculogenic mimicry.

作者信息

Wu Yanyuan, Du Kun, Guan Wenbin, Wu Di, Tang Haixiao, Wang Ning, Qi Jun, Gu Zhengqin, Yang Junyao, Ding Jie

机构信息

Department of Urology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai 200092, P.R. China.

Department of Laboratory, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai 200092, P.R. China.

出版信息

Oncol Lett. 2020 Nov;20(5):192. doi: 10.3892/ol.2020.12054. Epub 2020 Sep 3.

Abstract

The present study proposed the novel concept of total microvessel density (TMVD), which is the combination of the MVD and the vasculogenic mimicry (VM) status, and evaluated its clinical significance in patients with renal cell carcinoma (RCC). For that purpose, tumor samples from 183 patients with primary RCC were examined by CD34 single or periodic acid Schiff (PAS)/CD34 dual histology staining. MVD and VM were determined according to previous literature. Clinical information (tumor stage and grade, and duration of survival) was retrieved and analyzed. Survival information and VM-associated gene expression data of patients with RCC were also retrieved from The Cancer Genome Atlas (TCGA) database and the clinical significance of each individual gene was analyzed. The results indicated that MVD exhibited obvious differences among patients with RCC; however, it was not correlated with the stage/grade or length of survival in patients with RCC. In total, 81 patients (44.3%) were CD34(-)/PAS(+) and defined as VM(+), and they had a significantly shorter survival compared with that of VM(-) patients (P=0.0002). VM was not associated with MVD. TMVD was able to distinguish between patients with high and low MVD in terms of survival, thus TMVD was better compared with MVD alone at distinguishing between patients with different survival prognoses. TCGA data analysis revealed that among the VM-associated genes, nodal growth differentiation factor, caspase-3, matrix metalloproteinase-9 and galectin-3 had a statistically significant impact on the overall/disease-free survival of patients with RCC. In conclusion, the TMVD concept may be more appropriate and sensitive compared with the MVD or VM alone in predicting tumor aggressiveness and patient survival, particularly in RCC, which is a highly vascularized, VM-rich neoplasm, and certain VM formation-associated genes are negatively associated with the survival of patients with RCC.

摘要

本研究提出了总微血管密度(TMVD)这一新颖概念,它是微血管密度(MVD)与血管生成拟态(VM)状态的结合,并评估了其在肾细胞癌(RCC)患者中的临床意义。为此,采用CD34单染或过碘酸希夫(PAS)/CD34双染组织学方法对183例原发性RCC患者的肿瘤样本进行检测。根据既往文献确定MVD和VM。收集并分析临床信息(肿瘤分期和分级以及生存时间)。还从癌症基因组图谱(TCGA)数据库中获取RCC患者的生存信息和VM相关基因表达数据,并分析每个个体基因的临床意义。结果表明,RCC患者之间MVD存在明显差异;然而,它与RCC患者的分期/分级或生存时间无关。总共有81例患者(44.3%)为CD34(-)/PAS(+),被定义为VM(+),与VM(-)患者相比,他们的生存期明显更短(P = 0.0002)。VM与MVD无关。TMVD在区分不同生存预后的患者方面,在生存期上能够区分高MVD和低MVD患者,因此与单独的MVD相比,TMVD在这方面表现更好。TCGA数据分析显示,在与VM相关的基因中,结节生长分化因子、半胱天冬酶-3、基质金属蛋白酶-9和半乳糖凝集素-3对RCC患者的总生存/无病生存有统计学显著影响。总之,与单独的MVD或VM相比,TMVD概念在预测肿瘤侵袭性和患者生存方面可能更合适、更敏感,尤其是在RCC中,这是一种血管丰富、富含VM的肿瘤,并且某些与VM形成相关的基因与RCC患者的生存呈负相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c293/7479517/6aaf349f0445/ol-20-05-12054-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验